Theacrine Side Effects

Reported Theacrine side effects

At studied doses (100-300 mg/day), theacrine has a favorable side-effect profile in the controlled human trials — clinical chemistry and cardiovascular markers remained unchanged vs placebo across 8 weeks. That said, real-world reports identify several patterns worth knowing. Common (reported by >10% of users in community surveys): mild head pressure or pressure-sinus sensation in the first 60-90 minutes after dosing, typically resolving spontaneously. Some users report a subtle "body load" — a heaviness or slight muscle tension — that is distinctive from caffeine's peripheral jitter and usually mild. Occasional: nausea when taken on empty stomach at 250-300 mg (take with food), sleep disruption if taken after ~2 PM due to the long half-life, dry mouth, transient mild headache in the first 2-3 days of use. Less common but documented: irritability or agitation at doses above 400 mg, usually in stimulant-sensitive individuals or those co-dosing with high caffeine. Paradoxical fatigue has been reported by a small minority of users — plausibly linked to CYP1A2 polymorphism or individual dopaminergic responsiveness. Rare: palpitations (typically in combination with caffeine, not monotherapy). No documented cases of seizure, cardiac arrhythmia, or serious hepatotoxicity at studied doses. Interactions to be aware of: additive with caffeine (often desired, but dose-reduce both if stacking); theoretical MAOI interaction due to dopaminergic activity (avoid); potential increase in effect when stacked with other CYP1A2 substrates (fluvoxamine, ciprofloxacin, oral contraceptives containing ethinyl estradiol — all slow CYP1A2, extending theacrine exposure). Pregnancy and breastfeeding: no human data, avoid. Adolescents (<18): no safety data, avoid. Sleep is the most practical constraint. With a 16-20 hour half-life, a 200 mg morning dose still has roughly 40% of peak plasma at 10 PM. Users who take theacrine after 12-2 PM commonly report fragmented sleep or delayed sleep onset, and the long half-life means this cannot be offset by a post-dose sleep aid. The practical rule: morning dosing only, and skip if you need uncompromised sleep that night.

When to continue, reduce, or stop Theacrine

Theacrine contraindications

Absolute contraindications: known theacrine or xanthine hypersensitivity; uncontrolled hypertension (systolic >160 or diastolic >100 mmHg); ventricular arrhythmia or symptomatic atrial fibrillation; MAOI therapy (phenelzine, tranylcypromine, selegiline at psychiatric doses); pregnancy; breastfeeding; age under 18. Relative contraindications requiring clinician review: treated hypertension on beta-blockers, ACE inhibitors, or calcium-channel blockers; history of panic disorder or generalized anxiety disorder (dopaminergic activation can be anxiogenic in vulnerable individuals); bipolar disorder on stimulant-sensitive regimens; chronic kidney disease (eGFR <60) due to altered xanthine clearance; active gout or frequent hyperuricemia; concurrent use of high-dose caffeine (>400 mg/day) without first reducing caffeine intake; fluvoxamine, ciprofloxacin, or other strong CYP1A2 inhibitors. Drug interactions documented or theoretical: MAOIs (theoretical dopaminergic crisis — avoid); oral contraceptives containing ethinyl estradiol (slow CYP1A2, may extend theacrine exposure — monitor); high-dose caffeine (additive sympathomimetic — dose-reduce both); stimulant ADHD medications (amphetamine, methylphenidate) — the dopaminergic overlap is theoretical but concerning enough to warrant prescriber awareness. Pre-surgical: discontinue theacrine at least 48 hours before elective surgery due to the long half-life and theoretical cardiovascular sensitization under anesthesia. Exercise/competitive athletics: theacrine is NOT on the 2024 WADA prohibited list. It is permitted in most sport-governing bodies including NCAA, IOC, and UCI. Competitive athletes should verify with their specific governing body before use.

Why vendor quality drives Theacrine side-effect frequency

Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy.

Theacrine side effects FAQ

Research-use disclaimer. All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only.
Affiliate disclosure. See our affiliate disclosure .